ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2103

Synovial Inflammation Is Increased in Females with Knee Osteoarthritis

Caryn Hale1, Miguel Otero2, Dongmei Sun3, Michael Parides4, Edward Dicarlo5, dana Orange6, Yiyuan Wu7, William Robinson8, Bella Mehta5, Solana Cushing4, Peter Sculco4, Tristan Maerz9, Anne-Marie Malfait10, Daniel Ramirez11 and Aimee Colbath12, 1Memorial Sloan Kettering Cancer Center, New York, NY, 2Hospital for Special Surgery, NYC, 3Hospital for Special Surgery, Birmingham, AL, 4Hospital for Special Surgery, New York, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 6Rockefeller University, New York, NY, 7Weill Cornell Medicine, New York, NY, 8Division of Immunology and Rheumatology, Stanford University, and VA Palo Alto Health Care System, Stanford, CA, 9University of Michigan, Ann Arbor, MI, 10Rush University, New York, NY, 11Hospital for Special Surgery, Cartago, Costa Rica, 12Cornell University College of Veterinary Medicine, New York, NY

Meeting: ACR Convergence 2024

Keywords: Gene Expression, genetics, Osteoarthritis, Total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Symptomatic knee osteoarthritis (OA) is more common in women than men. We sought to compare clinical and histological features and synovial gene expression between females and males with knee OA. 

Methods: 135 patients undergoing Total Knee Arthroplasty (TKA) who met 1986 ACR classification criteria for knee OA were enrolled. Demographic and clinical characteristics including Erythrocyte Sedimentation Rate (ESR), high sensitivity C-Reactive Protein (hsCRP), Kellgren-Lawrence (KL) X-ray scores, and Osteoarthritis Research Society International (OARSI) cartilage scores were collected. Patient-reported pain was measured using the Knee Injury and Osteoarthritis Outcome Score (KOOS) pain subscale, Intermittent and Constant Osteoarthritis Pain Score (ICOAP), and pain Visual Analog Scale (VAS). Nine pathologist-scored synovial histology features were measured,1 and our computer vision pipeline was used to quantify cell density and cell aggregate number and size.2 RNA isolated from RNAlater-preserved synovium was used for bulk RNA-seq. cDNA libraries were prepared with KAPA-Stranded RNAseqKit with RiboErase, sequenced on a NovaSeq with 150 base pair paired end reads, targeting 100M reads per sample. Reads were pseudoaligned to Hg38 with Kallisto, and Limma was used to test for differentially expressed genes (DEGs). Gene set enrichment analysis (GSEA) and gene set variation analysis (GSVA) were used to test for differences in pathway and AMP phase 13 and 24 synovial cell subset enrichment according to sex.

Results: A total of 61% (82) of enrolled subjects were female. While there were no significant differences in OA severity (KL grade), OARSI score, or symptom duration between sexes, females had increased ESR and reported worse pain (Table 1). Females had higher synovial plasma cell, binucleate plasma cell, and mast cell numbers, and increased scores of cell density, number, and inflammatory aggregates. Males had increased synovial mucoid degeneration (Table 2). RNA seq uncovered 25 DEGs between sexes, of which 24 were encoded on the X or Y chromosome, or both (Figure 1A). GSEA identified 132 pathways associated with inflammation and immune activation significantly enriched in females vs. males, including  “adaptive immune response”, “complement activation”, “immunoglobulin complex” and “Fc epsilon receptor signaling pathways” (Figure 1B). One pathway involved in the regulation of androgen receptor signaling was significantly enriched in males. Synovial cell subset enrichment analyses showed increased B cell, T cell, NK cell, gd T cell, Nk T cell, Dendritic cells, and mast cell gene signatures in females (Figure 1C).

Conclusion: Despite similar OA severity and symptom duration, females had increased systemic and synovial tissue inflammation assessed by ESR, RNA-seq, and histology. Understanding the mechanisms underlying the association between sex, synovial inflammation and OA pain could provide therapeutic insight, and merits future investigation.

1) Orange et al, Arthritis Rheumatol 70, 690–701 (2018)

2) Frezza et al, Arthritis Rheumatol. 75, 2137–2147 (2023).

3&4) Zhang et al, Nat. Immunol. 20, 928–942 (2019) and Nature 623, 616–624 (2023).

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: C. Hale: None; M. Otero: Jannu Therapeutics, LLC, 8; D. Sun: None; M. Parides: None; E. Dicarlo: None; d. Orange: AstraZeneca, 2, Pfizer, 2; Y. Wu: None; W. Robinson: Atreca Inc, 2, 4, 8, Jansen, 5, Sanofi, 5; B. Mehta: None; S. Cushing: None; P. Sculco: BetterPT, 8, EOS Imaging, 2, HS2, LLC, 8, HSS ASC Development Network, LLC, 8, Interllijoint Surgical, Inc., 2, 5, 8, Joint Effort Administrative Services Organization, 8, Lima Corporate, 2, 9, Osgenic, 1, 8, Parvizi Surgical Innovation, LLC, 8, Tangen Biosciences, Inc., 8, ZIMMER BIOMET, 2, 5; T. Maerz: None; A. Malfait: None; D. Ramirez: None; A. Colbath: None.

To cite this abstract in AMA style:

Hale C, Otero M, Sun D, Parides M, Dicarlo E, Orange d, Wu Y, Robinson W, Mehta B, Cushing S, Sculco P, Maerz T, Malfait A, Ramirez D, Colbath A. Synovial Inflammation Is Increased in Females with Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/synovial-inflammation-is-increased-in-females-with-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-inflammation-is-increased-in-females-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology